CWM
BMY icon

Capital Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Capital Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,051
Closed -$310K – 39
2017
Q4 		$310K Buy
+5,051
New +$316K 0.27% 35

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Wealth Management's BMY Position: Q1 2018 in Review

Capital Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 5,051 shares — an estimated $310K sold.

Capital Wealth Management first reported a position in BMY in Q4 2017 and held it in 1 quarter. The position peaked at $310K in Q4 2017. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

  • Capital Wealth Management reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
  • Capital Wealth Management sold 5,051 Bristol-Myers Squibb shares in Q1 2018, an estimated $310K.
  • Capital Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 1 quarter.
  • Capital Wealth Management's Bristol-Myers Squibb position peaked at $310K in Q4 2017.
  • 1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on Capital Wealth Management's 13F filing for Q1 2018, filed 8 May 2018.